Act Two Investors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-50,226
Closed -$4.71M 47
2024
Q3
$4.71M Hold
50,226
0.89% 21
2024
Q2
$3.91M Buy
50,226
+45,225
+904% +$3.69M 0.77% 20
2024
Q1
$455K Sell
5,001
-53,473
-91% -$4.45M 0.09% 39
2023
Q4
$4.52M Sell
58,474
-11,750
-17% -$823K 0.98% 21
2023
Q3
$4.78M Buy
70,224
+39,016
+125% +$2.84M 1.28% 17
2023
Q2
$2.54M Sell
31,208
-167
-0.5% -$13.3K 0.71% 24
2023
Q1
$2.57M Buy
+31,375
New +$2.24M 1.03% 21

Other funds holding GEHC

Act Two Investors's GEHC Position: Q4 2024 in Review

Act Two Investors sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 50,226 shares — an estimated $4.71M sold.

Act Two Investors first reported a position in GEHC in Q1 2023 and held it in 7 quarters. The position peaked at $4.78M in Q3 2023. 1,327 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

  • Act Two Investors reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
  • Act Two Investors sold 50,226 GE HealthCare shares in Q4 2024, an estimated $4.71M.
  • Act Two Investors first reported a position in GE HealthCare in Q1 2023 and held it in 7 quarters.
  • Act Two Investors's GE HealthCare position peaked at $4.78M in Q3 2023.
  • 1,327 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Act Two Investors's 13F filing for Q4 2024, filed 13 Feb 2025.